Workflow
华恒生物: 安徽华恒生物科技股份有限公司2025年半年度报告摘要

Company Overview - Anhui Huaheng Biotechnology Co., Ltd. is listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board with the stock code 688639 [2] - The company reported total assets of approximately 5.30 billion RMB at the end of the reporting period, reflecting a 6.26% increase from the previous year [2] Financial Performance - The company's operating revenue for the reporting period reached approximately 1.49 billion RMB, marking a significant increase of 46.54% compared to the same period last year [2] - Total profit for the period was approximately 118.57 million RMB, which represents a decrease of 27.92% from the previous year [2] - The net profit attributable to shareholders of the listed company was approximately 114.76 million RMB, down 22.20% year-on-year [2] Shareholder Information - As of the end of the reporting period, the total number of shareholders was 8,247 [3] - The largest shareholder, Guo Henghua, holds 18.08% of the shares, amounting to 45,227,285 shares [3] - Other significant shareholders include Ningbo Ruiheyuan Venture Capital with 7.77% and China Agricultural Bank with 3.26% [3] Important Matters - The report indicates that there were no significant changes in the company's operating conditions during the reporting period [6]